Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 12 September 2015, Vol 295, No 7879

Sort by: Newest first Oldest first A-Z Z-A

  • Avastin not suitable for children Subscription

    8 SEP 2015 11:03

    The summary of product characteristics for Avastin (bevacizumab; Roche) has been updated to highlight that Avastin is not approved for use in patients aged under 18 years.

  • Discontinue ViraferonPeg Pen treatment with homicidal ideation Subscription

    8 SEP 2015 11:02

    The summary of product characteristics for ViraferonPeg Pen (peginterferon alfa-2b; Merck Sharp & Dohme) now recommends that treatment is discontinued if the patient experiences homicidal ideation. Additionally, pulmonary fibrosis and pulmonary arterial hypertension have been added as adverse events of unknown frequency.

  • Neuroleptic malignant syndrome with Latuda Subscription

    8 SEP 2015 10:59

    Neuroleptic malignant syndrome has been added as a rare adverse event in the summary of product characteristics for Latuda (lurasidone; Sunovion). 

  • Public Health England (PHE) is encouraging pregnant women to get immunised against whooping cough, an acute respiratory infection, to protect themselves and their babies. In the image, pregnant woman is vaccinated

    Pregnant women urged to get whooping cough vaccine Subscription

    8 SEP 2015 10:18

    Public Health England is encouraging pregnant women to get immunised against whooping cough, an acute respiratory infection caused by the bacterium Bordetella pertussis, to protect themselves and their babies.

  • The chair of the Royal Pharmaceutical Society’s (RPS) Welsh board, Mair Davies, pictured, has been appointed as the Society’s director for Wales

    RPS board chair appointed Wales director Subscription

    8 SEP 2015 9:52

    Mair Davies steps down from Welsh board to take on role within RPS executive.

  • Christine Buchanan van Doorn dies Subscription

    7 SEP 2015 17:03

    On 26 August 2015, Christine Buchanan van Doorn MRPharmS, aged 80, of Ceres, Fife. Mrs van Doorn registered with the Society in 1958.

  • William James Moore dies Subscription

    7 SEP 2015 17:02

    On 28 August 2015, William James Moore, known as Jim, aged 80, of Lyminge, Kent. Mr Moore registered with the Society in 1963 and left in 2004.  

  • Peter Digby Evans dies Subscription

    7 SEP 2015 16:59

    On 1 September 2015, Peter Digby Evans MRPharmS, aged 73, of Frodsham, Cheshire. Mr Evans registered with the Society in 1965.

  • The US Food and Drug Administration (FDA) has approved rolapitant (Varubi; Tesaro) as part of a combination of drugs to prevent nausea and vomiting caused by certain types of cancer chemotherapy. In the image, a woman receives chemotherapy

    FDA approves rolapitant to prevent chemotherapy-induced nausea Subscription

    7 SEP 2015 16:20

    The US Food and Drug Administration has approved rolapitant as part of a combination of drugs to prevent nausea and vomiting caused by certain types of cancer chemotherapy.

  • Simon Tweddell (pictured) brought team-based learning to students at the University of Bradford’s School of Pharmacy — and has secured a prize for his radical overhaul of the course.

    How pharmacy students are taught in teams Subscription

    7 SEP 2015 11:58 By Emma Page
    Comments (1)

    Simon Tweddell brought team-based learning to students at the University of Bradford’s School of Pharmacy — and has secured a prize for his radical overhaul of the course.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.